Devices & DosimetryVaginal CO₂ laser therapy appears well tolerated in the short term, but current evidence remains limited.
Study · September 9, 2026 · Jacobsen S et al.
Devices & DosimetryThe absence of a statistically significant difference between laser types does not establish equivalence; PS efficacy estimates were highly fragile and based on sparse data.
Review · August 6, 2026 · Li F et al.
Devices & DosimetryPBM + PDT shows synergistic therapeutic potential across multiple dental fields. Despite promising outcomes, heterogeneity in parameters remains a limitation.
Review · July 9, 2026 · Muntadir L et al.
Devices & DosimetryMixed pigmentary-vascular type is independently associated with poor response, aggravated by severe disease. For severe M + V-type, adjunctive anti-vascular or anti-inflammatory strategies may be warranted.
Study · June 10, 2026 · Li X et al.
Devices & DosimetryLaser-based therapies may provide beneficial adjunctive effects in MRONJ management, particularly within multimodal treatment strategies. However, the strength of these conclusions is limited due to substantial heterogeneity in study design, laser protocols and outcome reporting.
Review · May 14, 2026 · Grzech-Leśniak K et al.
Devices & DosimetryRadiographic examination revealed restoration of the cervical defect with Biodentine and preservation of the surrounding periodontal structures.
Study · April 19, 2026 · Kumari V et al.
Devices & DosimetryThese results indicate that PCL is a stable and effective carrier of LA, and that the observed combined effect of LLLT and LA influences the activity of resting macrophages, which may promote the creation of a favourable environment for regenerative processes.
Study · March 18, 2026 · Ścisłowska-Czarnecka A et al.
Devices & DosimetryThe present paper describes the clinical case of a 72-year-old male patient who, due to a large vestibular bone defect in Zone 1.1, required bone regeneration.
Study · February 11, 2026 · Vescovi P et al.
Devices & DosimetryOverall certainty is low due to small, heterogenous trials. Low rates of irreversible adverse events with PSAL may support trials in refractory cases, but long-term RCTs with larger sample sizes are required to evaluate durability and recurrence outcomes.
Review · January 26, 2026 · Chua KR et al.
Devices & DosimetryIn mesenteric arteries, the herbal treatment improved acetylcholine sensitivity but did not alter flow-induced or laser-induced vasodilation, especially under hypertensive conditions.
Study · December 29, 2025 · de Moraes LHO et al.
Devices & DosimetryAccording to IIEF-15 dynamics, LLLT and TENS are both very beneficial in treatment of post-COVID-19 ED, with LLLT showing a moderately better outcome than TENS.
Study · November 19, 2025 · Al-Zamil M et al.
Devices & DosimetrySubsequent tomographic imaging showed the bone neoformation. This case suggests that the combination of LLLT with B-Vit may serve as an adjunctive therapeutic alternative for the management of dysesthesia and paresthesia following the explantation of implants compressing the IAN.
Study · November 8, 2025 · Diaz-Campos JS et al.